P35659 (DEK_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 131.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Protein DEK | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 375 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Involved in chromatin organization. Ref.12 |
| Subunit structure | Found in a mRNA splicing-dependent exon junction complex (EJC) with DEK, RBM8A, RNPS1, SRRM1 and ALYREF/THOC4. Interacts with histones H2A, H2B, H3, H4, acetylated histone H4, non-phosphorylated DAXX and HDAC2. Component of the B-WICH complex, at least composed of SMARCA5/SNF2H, BAZ1B/WSTF, SF3B1, DEK, MYO1C, ERCC6, MYBBP1A and DDX21. Binds DNA. Ref.7 Ref.8 Ref.11 |
| Subcellular location | Nucleus. Note: Enriched in regions where chromatin is decondensed or sparse in the interphase nuclei. Ref.12 Ref.15 |
| Tissue specificity | Ubiquitous. Expressed at relatively high levels. |
| Post-translational modification | Phosphorylated by CK2. Phosphorylation fluctuates during the cell cycle with a moderate peak during G1 phase, and weakens the binding of DEK to DNA. Ref.9 |
| Involvement in disease | A chromosomal aberration involving DEK is found in a subset of acute myeloid leukemia (AML); also known as acute non-lymphocytic leukemia. Translocation t(6;9)(p23;q34) with NUP214/CAN. It results in the formation of a DEK-CAN fusion gene. |
| Sequence similarities | Contains 1 SAP domain. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P35659-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P35659-2) The sequence of this isoform differs from the canonical sequence as follows: 49-82: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.6 | |||||||||||||||||||||||||||||||
| Chain | 2 – 375 | 374 | Protein DEK | PRO_0000079858 | ||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||
| Domain | 149 – 183 | 35 | SAP | |||||||||||||||||||||||||||||||
| DNA binding | 337 – 351 | 15 | Ref.19 Ref.20 | |||||||||||||||||||||||||||||||
| DNA binding | 367 – 371 | 5 | Ref.19 Ref.20 | |||||||||||||||||||||||||||||||
| Motif | 205 – 221 | 17 | Nuclear localization signal Potential | |||||||||||||||||||||||||||||||
| Compositional bias | 30 – 49 | 20 | Asp/Glu-rich (highly acidic) | |||||||||||||||||||||||||||||||
| Compositional bias | 228 – 236 | 9 | Asp/Glu-rich (acidic) | |||||||||||||||||||||||||||||||
| Compositional bias | 241 – 254 | 14 | Asp/Glu-rich (acidic) | |||||||||||||||||||||||||||||||
| Compositional bias | 300 – 310 | 11 | Asp/Glu-rich (acidic) | |||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylserine Ref.6 Ref.16 Ref.18 | |||||||||||||||||||||||||||||||
| Modified residue | 13 | 1 | Phosphothreonine Ref.16 Ref.18 | |||||||||||||||||||||||||||||||
| Modified residue | 19 | 1 | Phosphoserine Ref.16 | |||||||||||||||||||||||||||||||
| Modified residue | 32 | 1 | Phosphoserine; by CK2 Ref.9 Ref.10 Ref.14 Ref.16 Ref.18 | |||||||||||||||||||||||||||||||
| Modified residue | 51 | 1 | Phosphoserine Ref.10 Ref.16 Ref.18 | |||||||||||||||||||||||||||||||
| Modified residue | 159 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 199 | 1 | Phosphothreonine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 201 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 204 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 210 | 1 | Phosphoserine Ref.16 | |||||||||||||||||||||||||||||||
| Modified residue | 227 | 1 | Phosphoserine Ref.10 | |||||||||||||||||||||||||||||||
| Modified residue | 230 | 1 | Phosphoserine Ref.10 Ref.16 | |||||||||||||||||||||||||||||||
| Modified residue | 231 | 1 | Phosphoserine Ref.10 Ref.16 | |||||||||||||||||||||||||||||||
| Modified residue | 232 | 1 | Phosphoserine Ref.10 Ref.16 | |||||||||||||||||||||||||||||||
| Modified residue | 243 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 244 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 251 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 287 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 288 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 289 | 1 | Phosphothreonine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 290 | 1 | Phosphothreonine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 296 | 1 | Phosphoserine; by CK2 Ref.9 | |||||||||||||||||||||||||||||||
| Modified residue | 301 | 1 | Phosphoserine; by CK2 Ref.9 Ref.18 | |||||||||||||||||||||||||||||||
| Modified residue | 303 | 1 | Phosphoserine; by CK2 Ref.9 Ref.18 | |||||||||||||||||||||||||||||||
| Modified residue | 306 | 1 | Phosphoserine; by CK2 Ref.9 Ref.16 Ref.18 | |||||||||||||||||||||||||||||||
| Modified residue | 307 | 1 | Phosphoserine; by CK2 Ref.9 Ref.13 Ref.16 Ref.18 | |||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||
| Alternative sequence | 49 – 82 | 34 | Missing in isoform 2. | VSP_042951 | ||||||||||||||||||||||||||||||
| Natural variant | 140 | 1 | V → A. Corresponds to variant rs17336208 [ dbSNP | Ensembl ]. | VAR_050949 | ||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||
| Turn | 88 – 90 | 3 | ||||||||||||||||||||||||||||||||
| Helix | 92 – 99 | 8 | ||||||||||||||||||||||||||||||||
| Helix | 103 – 112 | 10 | ||||||||||||||||||||||||||||||||
| Beta strand | 114 – 116 | 3 | ||||||||||||||||||||||||||||||||
| Helix | 121 – 128 | 8 | ||||||||||||||||||||||||||||||||
| Helix | 140 – 162 | 23 | ||||||||||||||||||||||||||||||||
| Turn | 163 – 165 | 3 | ||||||||||||||||||||||||||||||||
| Helix | 172 – 181 | 10 | ||||||||||||||||||||||||||||||||
| Turn | 182 – 184 | 3 | ||||||||||||||||||||||||||||||||
| Helix | 322 – 333 | 12 | ||||||||||||||||||||||||||||||||
| Helix | 338 – 340 | 3 | ||||||||||||||||||||||||||||||||
| Helix | 343 – 353 | 11 | ||||||||||||||||||||||||||||||||
| Beta strand | 355 – 357 | 3 | ||||||||||||||||||||||||||||||||
| Helix | 361 – 375 | 15 | ||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA." Von Lindern M., Fornerod M., Van Baal S., Jaegle M., De Wit T., Buijs A., Grosveld G. Mol. Cell. Biol. 12:1687-1697(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Testis. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Brain. |
| [3] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Cervix. |
| [6] | Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-21; 66-84; 94-100; 112-124; 126-137; 169-177; 179-187; 331-344 AND 349-362, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, MASS SPECTROMETRY. Tissue: Ovarian carcinoma. |
| [7] | "The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions." Le Hir H., Izaurralde E., Maquat L.E., Moore M.J. EMBO J. 19:6860-6869(2000) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A MRNA SPLICING-DEPENDENT EXON JUNCTION COMPLEX (EJC) WITH RBM8A; RNPS1; SRRM1 AND ALYREF/THOC4. |
| [8] | "Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek." Hollenbach A.D., McPherson C.J., Mientjes E.J., Iyengar R., Grosveld G. J. Cell Sci. 115:3319-3330(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DAXX. |
| [9] | "Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK." Kappes F., Damoc C., Knippers R., Przybylski M., Pinna L.A., Gruss C. Mol. Cell. Biol. 24:6011-6020(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-32; SER-159; THR-199; SER-201; SER-204; SER-243; SER-244; SER-251; SER-287; SER-288; THR-289; THR-290; SER-296; SER-301; SER-303; SER-306 AND SER-307. |
| [10] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; SER-51; SER-227; SER-230; SER-231 AND SER-232, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription." Cavellan E., Asp P., Percipalle P., Oestlund Farrants A.-K. J. Biol. Chem. 281:16264-16271(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE B-WICH COMPLEX. |
| [12] | "The distribution of the DEK protein in mammalian chromatin." Hu H.G., Scholten I., Gruss C., Knippers R. Biochem. Biophys. Res. Commun. 358:1008-1014(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32, MASS SPECTROMETRY. Tissue: Liver. |
| [15] | "Proteome analysis of human nuclear insoluble fractions." Takata H., Nishijima H., Ogura S., Sakaguchi T., Bubulya P.A., Mochizuki T., Shibahara K. Genes Cells 14:975-990(2009) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [16] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-19; SER-32; SER-51; SER-210; SER-230; SER-231; SER-232; SER-306 AND SER-307, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [18] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-32; SER-51; SER-301; SER-303; SER-306 AND SER-307, MASS SPECTROMETRY. |
| [19] | "Solution NMR structure of the C-terminal domain of the human protein DEK." Devany M., Kotharu N.P., Matsuo H. Protein Sci. 13:2252-2259(2004) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 309-375, DNA-BINDING. |
| [20] | "Solution NMR structure of the N-terminal domain of the human DEK protein." Devany M., Kappes F., Chen K.M., Markovitz D.M., Matsuo H. Protein Sci. 17:205-215(2008) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 78-208, DNA-BINDING. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X64229 mRNA. Translation: CAA45536.1. AK297749 mRNA. Translation: BAG60099.1. AK312616 mRNA. Translation: BAG35503.1. AL031774 Genomic DNA. Translation: CAI20082.2. CH471087 Genomic DNA. Translation: EAW55402.1. BC035259 mRNA. Translation: AAH35259.1. | ||||||||||||||||||
| IPI | IPI00020021. IPI00942944. | ||||||||||||||||||
| PIR | S26059. | ||||||||||||||||||
| RefSeq | NP_001128181.1. NM_001134709.1. NP_003463.1. NM_003472.3. | ||||||||||||||||||
| UniGene | Hs.484813. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | P35659. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P35659. 9 interactions. | ||||||||||||||||||
| MINT | MINT-2802925. | ||||||||||||||||||
| STRING | 9606.ENSP00000380414. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P35659. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 544150. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | P35659. | ||||||||||||||||||
| PeptideAtlas | P35659. | ||||||||||||||||||
| PRIDE | P35659. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 7913. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000244776; ENSP00000244776; ENSG00000124795. ENST00000397239; ENSP00000380414; ENSG00000124795. | ||||||||||||||||||
| GeneID | 7913. | ||||||||||||||||||
| KEGG | hsa:7913. | ||||||||||||||||||
| UCSC | uc003ncr.1. human. uc011djf.1. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 7913. | ||||||||||||||||||
| GeneCards | GC06M018224. | ||||||||||||||||||
| HGNC | HGNC:2768. DEK. | ||||||||||||||||||
| HPA | CAB015226. | ||||||||||||||||||
| MIM | 125264. gene. | ||||||||||||||||||
| neXtProt | NX_P35659. | ||||||||||||||||||
| Orphanet | 98277. Acute myeloid leukemia with recurrent genetic anomaly. | ||||||||||||||||||
| PharmGKB | PA27251. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG328552. | ||||||||||||||||||
| HOGENOM | HOG000059552. | ||||||||||||||||||
| HOVERGEN | HBG004944. | ||||||||||||||||||
| InParanoid | P35659. | ||||||||||||||||||
| OMA | DAINEMS. | ||||||||||||||||||
| OrthoDB | EOG4HHP3C. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P35659. | ||||||||||||||||||
| Bgee | P35659. | ||||||||||||||||||
| CleanEx | HS_DEK. | ||||||||||||||||||
| Genevestigator | P35659. | ||||||||||||||||||
| GermOnline | ENSG00000124795. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.10.10.60. 1 hit. | ||||||||||||||||||
| InterPro | IPR014876. DEK_C. IPR009057. Homeodomain-like. IPR003034. SAP_dom. [Graphical view] | ||||||||||||||||||
| Pfam | PF08766. DEK_C. 1 hit. PF02037. SAP. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00513. SAP. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS50800. SAP. False negative. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| ChiTaRS | DEK. human. | ||||||||||||||||||
| EvolutionaryTrace | P35659. | ||||||||||||||||||
| GenomeRNAi | 7913. | ||||||||||||||||||
| NextBio | 30376. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | DEK_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P35659 Secondary accession number(s): B2R6K6 Q5TGV5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
